3 - 8 days
EGFR MUTATION DETECTION FRAG
Looking to order a test?
We’ve provided helpful links to make ordering easy.Find a Requisition
All specimens should be accompanied by a requisition.Submitting Specimens
Learn about how to properly label and where to ship specimens.Order Kits and Supplies
MLabs provides all the supplies necessary for the collection of specimens.Test FAQ
Visit our provider FAQ and learn about common questions to ordering tests.
Multiplex PCR with capillary electrophoresis detection.
EGFR gene mutations occur in 10-40% of non-small cell lung cancer (NSCLC) cases. The most common mutations include exon 19 deletions and the exon 21 L858R substitution which together comprise ~85% of all EGFR mutations. The presence of either of these mutation types has been associated with clinical response to tyrosine kinase inhibitor therapies (gefitinib and erlotinib). This fragment analysis test will detect EGFR exon 19 deletion mutations and the L858R mutation in formalin fixed paraffin-embedded blocks, unstained paraffin sections on slides, and fresh/frozen tissue. The submitted specimen should contain an adequate proportion of tumor cells (> 5%) to enable mutation detection.
Interpretive report provided
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
For formalin-fixed, paraffin-embedded tissue, a block containing an area with a high percentage of neoplastic cells (for micro-/macro-dissection) is preferred. Unstained, UNBAKED slides (5-8, 10-micron slides; 10-15 if few neoplastic cells are present) with associated H&E stained slide are also acceptable. Decalcified tissue or other fixatives will be accepted and the assay attempted, however these may result in failed testing due to degraded nucleic acid. Both blocks and slides should be stored at room temperature. Diff-Quik stained aspirate smears (preferable containing a high percentage and overall amount of neoplastic cells) are acceptable. Store at room temperature.